Kobayashi Noriyasu, Kitazawa Riko, Maeda Sakan, Schurgers Leon, Kitazawa Sohei
Division of Molecular Pathology, Kobe University Graduate School of Medicine.
Kobe J Med Sci. 2004;50(3-4):69-81.
Matrix Gla protein (MGP) is a crucial inhibitor of vessel and cartilage calcification. We investigated the association of T-138C MGP promoter polymorphism with the degree of atherosclerosis, vascular calcification and patients' clinical background including calcification of the trachea and costal cartilage. Analysis of 108 autopsy cases was carried out by polymorphism-specific PCR on formalin-fixed paraffin-embedded samples. Statistical correlations among eight risk factors and five markers related to atherosclerosis and extra-bone tissue calcification were multivariantly analyzed. We found very high canonical correlations between the factors and the markers, and Pearson's correlation analysis revealed six significant correlations between age and the Gore index; age and costal cartilage calcification; sex and costal cartilage calcification; hypertension and the Gore index; hypertension and the calcification factor of the Gore index; and hyperlipidemia and costal cartilage calcification. The promoter activity of the -138T allele was significantly higher than that of the -138C allele; treatment with 12-O-tetradecanonylphorbol 13-acetate (TPA) significantly activated the former, but had almost no effect on the latter. The C genotype was significantly common among Japanese subjects, (TT 45.5%, TC 37.6% and CC 16.8%) compared with that reported in the Netherlands, Northern Ireland and France. No significant correlation was observed, however, between T-138C MGP promoter polymorphism and the markers. Although the C genotype (TC+CC) tended to show a higher calcification factor than the TT genotype, no significant difference was observed among the genotypes in the Gore index or in the calcification factor. Although MGP promoter activity and the binding of the AP-1 transcription factor were clearly different between T-138 and C-138 MGP promoter polymorphism in vitro, T-138C polymorphism was, statistically, not an independent factor of atherosclerosis or atherosclerotic vascular calcification in the abdominal aorta.
基质Gla蛋白(MGP)是血管和软骨钙化的关键抑制剂。我们研究了T-138C MGP启动子多态性与动脉粥样硬化程度、血管钙化以及患者临床背景(包括气管和肋软骨钙化)之间的关联。通过对福尔马林固定石蜡包埋样本进行多态性特异性PCR,对108例尸检病例进行了分析。对与动脉粥样硬化和骨外组织钙化相关的8个风险因素和5个标志物之间的统计相关性进行了多变量分析。我们发现这些因素与标志物之间存在非常高的典型相关性,Pearson相关性分析揭示了年龄与戈尔指数、年龄与肋软骨钙化、性别与肋软骨钙化、高血压与戈尔指数、高血压与戈尔指数钙化因子以及高脂血症与肋软骨钙化之间的6个显著相关性。-138T等位基因的启动子活性显著高于-138C等位基因;用12-O-十四烷酰佛波醇-13-乙酸酯(TPA)处理可显著激活前者,但对后者几乎没有影响。与荷兰、北爱尔兰和法国报道的情况相比,C基因型在日本受试者中显著常见(TT为45.5%,TC为37.6%,CC为16.8%)。然而,未观察到T-138C MGP启动子多态性与这些标志物之间存在显著相关性。尽管C基因型(TC+CC)的钙化因子往往高于TT基因型,但在戈尔指数或钙化因子方面,各基因型之间未观察到显著差异。虽然在体外,T-138和C-138 MGP启动子多态性之间的MGP启动子活性和AP-1转录因子的结合明显不同,但从统计学角度来看,T-138C多态性不是腹主动脉中动脉粥样硬化或动脉粥样硬化血管钙化的独立因素。